Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134707) titled 'A long-term extended study on the use of Enpatoran in the treatment of lupus skin manifestations with or without systemic diseases' on Oct. 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: West China Hospital of Sichuan University
Condition:
lupus erythematosus
Recruitment Status: Not Recruiting
Phase: 3
Date of First Enrollment: 2027-03-01
Target Sample Size: experimental group:404;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=348338
Disclaimer: Curated by HT Syndication....